Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bongbimit
    Member
    • Dec 2013
    • 29

    #1

    different between snp and point mutation in ngs data set

    Hi all,
    I 'm confusing about this 2 terms, i already know that in population if frequency >1% the alternative base is called snp and if <1% it called point mutation, but if i sequencing a blood sample and i have a reference genome to align my ngs dataset, how do i know the variant call from software ( e.g samtool ) is snp or point mutation.

    Thanks all in advance.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    You can't magically determine prevalence without sequencing a LOT of people and directly measuring its frequency.

    Comment

    • rhinoceros
      Senior Member
      • Apr 2013
      • 372

      #3
      The point mutation concept also includes indels, whereas SNPs are strictly substitutions. Hence, SNPs are a subtype of point mutations. The 1% SNP/point mutation divide isn't valid. A SNP is a SNP, no matter its frequency. A common SNP is a SNP that has ≥ 1% frequency..

      The HapMap project focuses only on common SNPs, those where each allele occurs in at least 1% of the population.
      Last edited by rhinoceros; 03-28-2014, 01:52 AM.
      savetherhino.org

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2





        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification,...
        10-30-2026, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 07:59 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 11-05-2026, 09:25 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 11-03-2026, 11:54 AM
      0 responses
      47 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      172 views
      0 reactions
      Last Post SEQadmin2  
      Working...